Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 20;293(6549):709–710. doi: 10.1136/bmj.293.6549.709

The pill and breast cancer: why the uncertainty?

K McPherson, J O Drife
PMCID: PMC1341438  PMID: 3094619

Full text

PDF
709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clavel F., Benhamou E., Sitruk-Ware R., Mauvais-Jarvis P., Flamant R. Breast cancer and oral contraceptives: a review. Contraception. 1985 Dec;32(6):553–569. doi: 10.1016/s0010-7824(85)80002-0. [DOI] [PubMed] [Google Scholar]
  2. Drife J. O. Breast development in puberty. Ann N Y Acad Sci. 1986;464:58–65. doi: 10.1111/j.1749-6632.1986.tb15993.x. [DOI] [PubMed] [Google Scholar]
  3. Greenberg E. R., Barnes A. B., Resseguie L., Barrett J. A., Burnside S., Lanza L. L., Neff R. K., Stevens M., Young R. H., Colton T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med. 1984 Nov 29;311(22):1393–1398. doi: 10.1056/NEJM198411293112201. [DOI] [PubMed] [Google Scholar]
  4. McPherson K., Coope P. A. Early oral contraceptive use and breast cancer risk. Lancet. 1986 Mar 22;1(8482):685–686. doi: 10.1016/s0140-6736(86)91765-4. [DOI] [PubMed] [Google Scholar]
  5. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  6. Oka T., Yoshimura M. Paracrine regulation of mammary gland growth. Clin Endocrinol Metab. 1986 Feb;15(1):79–97. doi: 10.1016/s0300-595x(86)80043-3. [DOI] [PubMed] [Google Scholar]
  7. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  8. Rosenberg L., Miller D. R., Kaufman D. W., Helmrich S. P., Stolley P. D., Schottenfeld D., Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. doi: 10.1093/oxfordjournals.aje.a113735. [DOI] [PubMed] [Google Scholar]
  9. Rothman K. J. Induction and latent periods. Am J Epidemiol. 1981 Aug;114(2):253–259. doi: 10.1093/oxfordjournals.aje.a113189. [DOI] [PubMed] [Google Scholar]
  10. Stadel B. V., Rubin G. L., Webster L. A., Schlesselman J. J., Wingo P. A. Oral contraceptives and breast cancer in young women. Lancet. 1985 Nov 2;2(8462):970–973. doi: 10.1016/s0140-6736(85)90524-0. [DOI] [PubMed] [Google Scholar]
  11. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES